MEDICINE DETAILS
Keytruda
Active ingredient: Pembrolizumab
Neutral reference profile for an independent medicine-access consultancy enquiry about Keytruda (Pembrolizumab). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Keytruda used for?
Keytruda (pembrolizumab) is a monoclonal antibody (immunotherapy) indicated for the treatment of people with:
- advanced (unresectable or metastatic) melanoma
- metastatic nonsquamous NSCLC as first-line treatment in combination with pemetrexed and carboplatin
- recurrent or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
- recurrent classical Hodgkin Lymphoma (cHL)
- locally advanced or metastatic urothelial carcinoma
- solid tumors having the biomarkers MSI-H or dMMR
- recurrent locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma
- advanced renal cell carcinoma (RCC)
- locally recurrent unresectable or metastatic triple-negative breast cancer (TNBC) whose tumors express PD-L1.
It is available as a powder for intravenous infusion (drip) containing 100mg of pembrolizumab per vial.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Keytruda identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
25 mg/ml (100 mg/4 ml vial) concentrate for solution for infusion · 2 vials (4 ml each) Catalogue organisation: MSD Sharp & Dohme GmbH
-
25 mg/ml (100 mg/4 ml vial) infusion concentrate · 4 ml Catalogue organisation: MSD Sharp & Dohme GmbH
OFFICIAL SOURCES
Check the Keytruda record at an official source.
Search for “Keytruda” or “Pembrolizumab”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Keytruda.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Keytruda
01What is Keytruda?＋
This directory record associates the brand name Keytruda with the active ingredient Pembrolizumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Keytruda strengths and packs are recorded?＋
The catalogue currently shows: 25 mg/ml (100 mg/4 ml vial) concentrate for solution for infusion · 2 vials (4 ml each); 25 mg/ml (100 mg/4 ml vial) infusion concentrate · 4 ml. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Keytruda?＋
Catalogue records currently name: MSD Sharp & Dohme GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Keytruda?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Keytruda, payment request, stock guarantee or binding offer.
06Can I buy Keytruda from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.